NEW POTENTIAL OF PHARMACEUTICAL THERAPY IN DIASTOLIC CHRONIC HEART FAILURE TREATMENT

NEW POTENTIAL OF PHARMACEUTICAL THERAPY IN DIASTOLIC CHRONIC HEART FAILURE TREATMENT

.

Saved in:

Bibliographic Details
Main Authors:	A. S. Adamchik, I. V. Kryuchkova, G. M. Ruban, Yu. A. Blagodyreva
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2010-08-01
Series:	Российский кардиологический журнал
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/1467
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Taurine effects on 24-hour blood pressure monitoring parameters in patients with chronic heart failure and metabolic syndrome
by: I. V. Kryuchkova, et al.
Published: (1970-01-01)

Remodeling variants and diastolic filling at various stages of diastolic chronic heart failure
by: I. A. Zavodchikova, et al.
Published: (2005-04-01)

AFFECTIVE DISORDERS IN PATIENTS WITH DIASTOLIC CHRONIC HEART FAILURE
by: V. A. Lusov, et al.
Published: (2010-06-01)

Chronic heart failure with normal left ventricular systolic function (diastolic heart failure)
by: B. Ya. Bart, et al.
Published: (2007-02-01)

Modern concept of diastolic heart failure
by: F. T. Ageev
Published: (1970-01-01)

Diastolic heart failure: boundaries of term application
by: V. V. Kalyuzhin, et al.
Published: (2023-04-01)

CLINICAL COURSE, PROGNOSIS AND THERAPY OF CHRONIC HEART FAILURE IN PATIENTS WITH NORMAL SYSTOLIC AND DIASTOLIC LEFT VENTRICLE FUNCTION
by: I. A. Sharoshina, et al.
Published: (2003-12-01)

EFFECT OF SIMVASTATIN THERAPY ON INDICATORS OF TRANSMITRAL BLOOD FLOW IN PATIENTS WITH DIASTOLIC HEART FAILURE
by: T. V. Pinchuk, et al.
Published: (2015-09-01)

INTRACORONARY AUTOLOGOUS BONE MARROW STEM CELL THERAPY IN DIASTOLIC HEART FAILURE
by: V. I. Shumakov, et al.
Published: (2009-06-01)

Metabolic disturbances and endothelial function in elderly patients with systolic and diastolic chronic heart failure
by: I. A. Sukmanova, et al.
Published: (2009-10-01)

Dependence of renal filtration capacity on the phenotype of chronic heart failure, indicators of systolic and diastolic heart function
by: V. V. Syvolap, et al.
Published: (2021-05-01)

CHANGING SYTOLIC AND DIASTOLIC LV FUNCTION IN CHRONIC HEART FAILURE UNDER THE INFLUENCE OF METOPROLOL
by: T. S. Jahangirov, et al.
Published: (2001-10-01)

Left and right ventricular diastolic dysfunction in patients with coronary heart disease and initial stages of chronic heart failure
by: Z. O. Georgadze, et al.
Published: (1970-01-01)

ANTIISCHEMIC AND ANTIARRHYTHMIC EFFECTS OF SIMVASTATIN IN PATIENTS WITH DIASTOLIC HEART FAILURE
by: T. V. Pinchuk, et al.
Published: (2013-12-01)

Non-pharmaceutical rehabilitation of chronic heart failure patients
by: M. T. Kudaev, et al.
Published: (2006-02-01)

CARBOHYDRATE METABOLISM DISTURBANCES: THERAPEUTIC POTENTIAL IN METABOLIC SYNDROME
by: I. V. Kryuchkova, et al.
Published: (2009-04-01)

THE ROLE OF OXIDATIVE STRESS AND ENDOTHELIAL DYSFUNCTION IN DIASTOLIC CHRONIC HEART FAILURE PATIENTS OF VARIOUS AGE GROUPS
by: I. A. Sukmanova, et al.
Published: (2009-08-01)

EFFECTS OF TRIMETAZIDINE ON THE TRANSMITRAL BLOOD FLOW IN PATIENTS WITH DIASTOLIC HEART FAILURE
by: Yu. N. Fedulaev, et al.
Published: (2015-09-01)

NEW POTENTIAL OF PHARMACEUTICAL CORRECTION OF CARDIAC AUTONOMIC NEUROPATHY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CHRONIC HEART FAILURE
by: M. E. Statsenko, et al.
Published: (2011-10-01)

Prognostic values of the diastolic index as a marker of chronic heart failure with preserved left ventricular ejection fraction
by: V. V. Syvolap, et al.
Published: (2024-02-01)

Effect of spironolactone on transmitral diastolic blood flow and course of chronic heart failure with preserved left ventricular ejection fraction
by: V. A. Vasylenko
Published: (2015-10-01)

HEART RATE-LOWERING THERAPY IN THE TREATMENT OF CHRONIC HEART FAILURE
by: S. V. Shalaev, et al.
Published: (2015-09-01)

ACE inhibitor lisinopril influence on left ventricular diastolic dysfunction and endothelial response in hypertensive patients with or without chronic heart failure
by: A. D. Kuimov, et al.
Published: (2004-06-01)

The Relationship of Endothelial Dysfunction with the Development of Diastolic Heart Failure in Patients with Hypertension
by: T. V. Kalinkina, et al.
Published: (2020-07-01)

Effect of Ivabradine on Endothelial Function in Diastolic and Right Heart Failure Patients
by: Arturo Orea-Tejeda, et al.
Published: (2013-01-01)

Similarities and Differences between the Pathogenesis and Pathophysiology of Diastolic and Systolic Heart Failure
by: Kazuo Komamura
Published: (2013-01-01)

Features of structural and geometric remodeling of the heart and changes in heart diastolic filling in patients with chronic heart failure of ischemic genesis with reduced left ventricular ejection fraction
by: V. A. Lysenko
Published: (2021-02-01)

Cognitive impairment in chronic heart failure. How new therapeutic options for the treatment of chronic heart failure affect cognitive function?
by: Y. O. Aksenova, et al.
Published: (2024-03-01)

EFFICACY OF IVABRADINE AND VERAPAMIL IN PATIENTS WITH DIASTOLIC HEART FAILURE CAUSED BY LEFT VENTRICLE IMPAIRED RELAXATION
by: K. G. Adamyan, et al.
Published: (2016-01-01)

NEW OPPORTUNITIES IN TREATMENT OF CHRONIC HEART FAILURE WITH NORMAL EJECTION FRACTION
by: A. G. Dushina, et al.
Published: (2015-08-01)

Features of structural and geometric remodeling of the heart and changes in the diastolic filling of the heart in patients with chronic heart failure of ischemic genesis with preserved left ventricular ejection fraction
by: V. A. Lysenko, et al.
Published: (2021-03-01)

Myocardial revascularization results: electrical, structural, and geometric left ventricular remodelling in diastolic heart failure
by: I. P. Tatarchenko, et al.
Published: (1970-01-01)

Heart failure with preserved ejection fraction: the role of diastolic stress test in diagnostic algorithms
by: E. N. Pavlyukova, et al.
Published: (2021-03-01)

ROLE OF THE METABOLITE THERAPY FOR THE TREATMENT OF CHRONIC HEART FAILURE
by: L. N. Maksimova, et al.
Published: (2015-09-01)

NEW POTENTIAL OF MEXICOR IN THE TREATMENT OF CHRONIC HEART FAILURE AMONG PATIENTS WITH METABOLIC SYNDROME
by: M. E. Statsenko, et al.
Published: (2010-12-01)

AFFECTIVE DISORDERS AND QUALITY OF LIFE IN PATIENTS WITH ARTERIAL HYPERTENSION AND DIASTOLIC HEART FAILURE
by: S. N. Molchanov, et al.
Published: (2009-10-01)

Training‐induced change of diastolic function in heart failure with preserved ejection fraction
by: Andreas B. Gevaert, et al.
Published: (2025-06-01)

Pharmaceutical correction of symptoms and heart remodeling in refractory forms of chronic heart failure and left ventricular dysfunction
by: V. E. Malikov, et al.
Published: (2008-10-01)

THE "NEW" DRUG CLASSES IN THE TREATMENT OF CHRONIC HEART FAILURE AND THEIR EVIDENCE BASE
by: S. N. Tereshchenko, et al.
Published: (2015-12-01)

Analysis of the relationship between systemic inflammation and diastolic dysfunction in patients with heart failure and rheumatoid arthritis
by: A. S. Ankudinov, et al.
Published: (2020-07-01)